Literature DB >> 28382908

Consider Ineffectiveness.

Marcus Schiltenwolf.   

Abstract

Year:  2017        PMID： 28382908      PMCID： PMC5387854          DOI： 10.3238/arztebl.2017.0192c

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

Review 1.  Pharmacologic management of neuropathic pain: evidence-based recommendations.

Authors:  Robert H Dworkin; Alec B O'Connor; Miroslav Backonja; John T Farrar; Nanna B Finnerup; Troels S Jensen; Eija A Kalso; John D Loeser; Christine Miaskowski; Turo J Nurmikko; Russell K Portenoy; Andrew S C Rice; Brett R Stacey; Rolf-Detlef Treede; Dennis C Turk; Mark S Wallace
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

Review 2.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

Review 3.  The Pharmacological Therapy of Chronic Neuropathic Pain.

Authors:  Andreas Binder; Ralf Baron
Journal:  Dtsch Arztebl Int       Date:  2016-09-16       Impact factor: 5.594

4.  A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component.

Authors:  J Hampton Atkinson; Mark A Slater; Edmund V Capparelli; Shetal M Patel; Tanya Wolfson; Anthony Gamst; Ian S Abramson; Mark S Wallace; Stephen D Funk; Thomas R Rutledge; Julie L Wetherell; Scott C Matthews; Sidney Zisook; Steven R Garfin
Journal:  Pain       Date:  2016-07       Impact factor: 7.926
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.